Compare NEWP & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NEWP | LYEL |
|---|---|---|
| Founded | 1972 | 2018 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 575.1M | 490.1M |
| IPO Year | 2006 | 2021 |
| Metric | NEWP | LYEL |
|---|---|---|
| Price | $4.13 | $19.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $6.00 | ★ $27.25 |
| AVG Volume (30 Days) | ★ 948.3K | 100.2K |
| Earning Date | 01-01-0001 | 06-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $36,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.93 | $0.39 |
| 52 Week High | $5.89 | $45.00 |
| Indicator | NEWP | LYEL |
|---|---|---|
| Relative Strength Index (RSI) | 44.98 | 36.99 |
| Support Level | $3.31 | $15.82 |
| Resistance Level | $4.70 | $27.30 |
| Average True Range (ATR) | 0.34 | 2.02 |
| MACD | -0.15 | -0.28 |
| Stochastic Oscillator | 6.28 | 6.05 |
New Pacific Metals Corp is a Canadian Mining Issuer, in the business of exploring and developing precious metal properties in Bolivia. The company's projects which are also its reportable segments include Silver Sand; Carangas and Silverstrike.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.